"I look forward to seeing the global changes they make in the medical world over the next few years.”
Evanston, Illinois (PRWEB) November 29, 2016
Preora Diagnostics Inc., a privately held medical technology company developing low-cost and highly accurate cancer screening tests, received Corporate LiveWire’s 2016 award for “Best in Cancer Diagnostics” in the Americas.
According to the United Kingdom-based Corporate LiveWire, the 2016 awards “celebrate the most innovative and successful projects carried out around the world over the past 12 months.” In addition to diagnostics, eligible sectors included health administration, insurance providers, pharmaceuticals and healthcare providers.
In its news release highlighting the guide that announces this year’s winners, Jake Powers, awards director of the 2016 Healthcare and Life Science Awards, said, “Each winner in this guide has played a big part in biology, medicine, and life sciences. I look forward to seeing the global changes they make in the medical world over the next few years.”
About Preora Diagnostics
Preora Diagnostics Inc. is dedicated to helping people survive cancer through a proven, two-tiered approach to early detection. The company develops proprietary, low-cost, minimally invasive, highly sensitive and highly specific cancer screening tests using technology that detects and measures cellular changes at the nanoscale level. The screening tests are based on the proprietary Partial Wave Spectroscopy (PWS) Nanocytology platform, licensed exclusively by Preora through NanoCytomics, LLC and Northwestern University. The Wall Street Journal has named PWS Nanocytology as one of “Six New Medical Technologies Worth Watching,” and Corporate LiveWire honored the company with its “2016 Best in Cancer Diagnostics” award. For more information, visit http://www.PreoraDx.com.